期刊文献+

阿司匹林、奥扎格雷、氯吡格雷与肝素对预防冠状动脉支架亚急性血栓形成的影响 被引量:1

Effect of spirin, Ozagrel, Lübigelei and Heparin on preventing subacute coronary stent thronbosis
下载PDF
导出
摘要 ①目的 观察阿司匹林、奥扎格雷、氯吡格雷与肝素对预防冠状动脉支架亚急性血栓形成的影响。②方法 对46例冠心病患者置入50枚支架,冠心病心绞痛患者术前均以阿司匹林300mg、奥扎格雷120mg、氯吡格雷75mg,均每天应用1次。急性心肌梗死患者术前2h给予氯吡格雷300mg。穿刺成功后注射肝素8000~10000U,后每小时增加1000~2000U,术后4h待ACT<150s后拔除鞘管。术后次日口服阿司匹林300mg,1次/d,连用3个月,氯吡格雷75mg,1次/d,连用1个月,奥扎格雷120mg,1次/d,连用半个月,低分子肝素5000U,皮下注射,2次/d,维持5~7d。③结果 随诊3个月未见亚急性血栓形成。④结论 阿司匹林、奥扎格雷、氯吡格雷与肝素联合疗法对预防亚急性血栓形成(subacute stent thrombosis,SST)既有效,又安全。
出处 《华北煤炭医学院学报》 2003年第4期417-418,共2页 Journal of North China Coal Medical College
  • 相关文献

参考文献5

  • 1[1]Mak KH;Bellia, Ellis Sa,et al. Subacute stent thrambosis:evolving issues and curreut concepts. JACC, 1996,27 ( 2 ) :494 ~ 503.
  • 2[2]Nath CF Muller DWM, Ellis Sa, et al. Thrombosis of a flexible eoil Coronary Stent: Frequency. Predictors and Clical outcome . JACC,1993,21 (4) ;622 ~627.
  • 3[3]Foley JB, Brown RIG , Penn IM . Thrombosis and restenosis after scending in failed antioplasty comparison with elective stenting. Am Heart J,1994,128(3):132.
  • 4颜红兵,马长生,王勇,柯元南.联合应用阿司匹林、抵克力得和肝素预防亚急性冠状动脉支架血栓形成[J].中国介入心脏病学杂志,1998,6(1):4-6. 被引量:19
  • 5[5]Michiniko TADA, Shiro H, Tsu NEK. Augented platelet reactivity and thrombonane A2 production possible aggravating factors in unstable angina. Japan Circulation Journal, 1986,35( 1 ) :181 ~ 187.

共引文献18

同被引文献25

  • 1陈立娟,马根山,冯毅,沈成兴,陈忠,章晓国.紫杉醇药物涂层支架治疗左前降支病变临床研究[J].东南大学学报(医学版),2006,25(6):423-426. 被引量:13
  • 2刘斌,李淑梅,张基昌,史永锋.生物可降解高分子材料载内皮前体细胞CD34抗体涂层支架防治犬冠脉再狭窄的研究[J].中国实验诊断学,2007,11(3):369-371. 被引量:18
  • 3尹学亮,李志梁,傅强,吴宏超,严全能,赵霞,刘映峰.氯吡格雷联合普通肝素在多个药物支架植入术后抗凝的应用[J].广东医学,2007,28(5):810-812. 被引量:3
  • 4Trabattoni D,Fabbiocchi F,Montorsi P,et al.Stent thrombosis after sirolimus-and paclitaxel-eluting stent implantation in daily clinical practice:analysis of a single center registry.Catheter Cardiovasc Interv.2007;70(3):415-421.
  • 5Kereiakes D J,Choo JK,Young JJ,et al.Thrombosis and drug-eluting stents:a critical appraisal.Rev Cardiovasc Med.2004;5(1):9-15.
  • 6Fenwei W,Stouffer GA,Waxman S,et al.Late coronary stent thrombosis:Early vs.late stent thrombosis in the stent era.Commentary.Catheterization and Cardiovascular Interventions.2002;55(2):142-149.
  • 7Mauri L,Hsieh WH,Massaro JM,et al.Stent thrombosis in randomized clinical trials of drug-eluting stents.N Engl J Med.2007;356(10):1020-1029.
  • 8Cutlip DE,Windecker S,Mehran R,et al.Clinical end points in coronary stent trials:a case for standardized definitions.Circulation.2007;115(17):2344-2351.
  • 9Togni M,Raber L,Cocchia R,et al.Local vascular dysfunction after coronary paclitaxel-eluting stent implantation.Int J Cardiol.2007;120(2):212-220.
  • 10Vats HS,Hocking WG,Rezkalla SH.Suspected clopidogrel resistance in a patient with acute stent thrombosis.Nat Clin Pract Cardiovasc Med.2006;3(4):226-230.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部